Back to today’s briefing

Story perspectives

Study: Sulthiame Shows Promise for Sleep Apnea Relief

3/13/2026

48 9 Full Breakdown

Summary

Story summary

Sulthiame, used in Europe for epilepsy, may improve breathing in obstructive sleep apnea, with higher doses reducing interruptions by up to 47% in 298 adults across four European countries.
The Lancet published the findings, led by Jan Hedner, suggesting potential new treatments as CPAP remains uncomfortable.
The study indicates sulthiame could address root causes of sleep apnea, but further studies are needed to confirm these results.

1 of 1

Story summary

Sulthiame, used in Europe for epilepsy, may improve breathing in obstructive sleep apnea, with higher doses reducing interruptions by up to 47% in 298 adults across four European countries.
The Lancet published the findings, led by Jan Hedner, suggesting potential new treatments as CPAP remains uncomfortable.
The study indicates sulthiame could address root causes of sleep apnea, but further studies are needed to confirm these results.